• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ATM 抑制使肿瘤对大剂量辐射敏感。

ATM Inhibition Sensitizes Tumors to High-Dose Irradiation.

机构信息

Washington University School of Medicine, St. Louis, Missouri.

出版信息

Cancer Res. 2019 Feb 15;79(4):704-705. doi: 10.1158/0008-5472.CAN-18-4072.

DOI:10.1158/0008-5472.CAN-18-4072
PMID:30770366
Abstract

Mechanistic studies of high-dose irradiation are important to improve our understanding on how the efficacy of stereotactically delivered high-dose irradiation can be enhanced by therapeutics such as ataxia-telangiesctasia-mutated (ATM) inhibitors. In this issue of , Torok and colleagues found that a single 15 Gy radiation dose eliminated lung tumor growth in mice when ATM was deleted in cancer cells versus when deleted in endothelial cells. These data support the establishment of clinical trials testing ATM inhibitors in combination with highly conformal radiotherapy or high-dose rate brachytherapy..

摘要

研究大剂量照射的作用机制对于加深理解如何通过诸如共济失调毛细血管扩张突变(ATM)抑制剂等治疗方法增强立体定向给予大剂量照射的疗效非常重要。在本期杂志中,Torok 及其同事发现,与在血管内皮细胞中敲除 ATM 相比,在癌细胞中敲除 ATM 时,单次 15 Gy 的辐射剂量可消除小鼠肺部肿瘤的生长。这些数据支持建立临床试验,以测试 ATM 抑制剂与高适形放疗或高剂量率近距离放疗相结合的效果。

相似文献

1
ATM Inhibition Sensitizes Tumors to High-Dose Irradiation.ATM 抑制使肿瘤对大剂量辐射敏感。
Cancer Res. 2019 Feb 15;79(4):704-705. doi: 10.1158/0008-5472.CAN-18-4072.
2
Deletion of in Tumor but not Endothelial Cells Improves Radiation Response in a Primary Mouse Model of Lung Adenocarcinoma.肿瘤细胞而非内皮细胞中 缺失可改善肺腺癌原代小鼠模型的放疗反应。
Cancer Res. 2019 Feb 15;79(4):773-782. doi: 10.1158/0008-5472.CAN-17-3103. Epub 2018 Oct 12.
3
Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.通过联合靶向 DNA 依赖性蛋白激酶和碳离子放疗克服非小细胞肺癌缺氧诱导的肿瘤放射抵抗。
Radiat Oncol. 2017 Dec 29;12(1):208. doi: 10.1186/s13014-017-0939-0.
4
MicroRNA-223 enhances radiation sensitivity of U87MG cells in vitro and in vivo by targeting ataxia telangiectasia mutated.MicroRNA-223 通过靶向 ataxia telangiectasia mutated 增强 U87MG 细胞在体外和体内的辐射敏感性。
Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):955-60. doi: 10.1016/j.ijrobp.2013.12.036.
5
Deficiency Is Associated with Sensitivity to PARP1- and ATR Inhibitors in Lung Adenocarcinoma.缺陷与肺腺癌对 PARP1 和 ATR 抑制剂的敏感性相关。
Cancer Res. 2017 Jun 1;77(11):3040-3056. doi: 10.1158/0008-5472.CAN-16-3398. Epub 2017 Mar 31.
6
[Relationship of HepG2 cell sensitivity to continuous low dose-rate irradiation with ataxia-telangiectasia mutated phosphorylation].[人肝癌细胞株HepG2对连续低剂量率照射的敏感性与共济失调毛细血管扩张症突变蛋白磷酸化的关系]
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Sep;27(9):1391-5.
7
ATM protein is deficient in over 40% of lung adenocarcinomas.超过40%的肺腺癌中存在ATM蛋白缺陷。
Oncotarget. 2016 Sep 6;7(36):57714-57725. doi: 10.18632/oncotarget.9757.
8
Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells.共济失调毛细血管扩张症突变激活介导肿瘤坏死因子-α诱导肺癌细胞中基质金属蛋白酶-13的上调和转移。
Oncotarget. 2016 Sep 20;7(38):62070-62083. doi: 10.18632/oncotarget.11386.
9
The role of the ataxia telangiectasia mutated gene in lung cancer: recent advances in research.共济失调毛细血管扩张突变基因在肺癌中的作用:研究新进展。
Ther Adv Respir Dis. 2017 Sep;11(9):375-380. doi: 10.1177/1753465817725716. Epub 2017 Aug 21.
10
Role of ATM in bystander signaling between human monocytes and lung adenocarcinoma cells.ATM在人单核细胞与肺腺癌细胞间旁观者信号传导中的作用。
Mutat Res Genet Toxicol Environ Mutagen. 2015 Dec;794:39-45. doi: 10.1016/j.mrgentox.2015.10.003. Epub 2015 Oct 23.

引用本文的文献

1
DNA repair deficiency and the immune microenvironment: A pathways perspective.DNA 修复缺陷与免疫微环境:一种途径视角。
DNA Repair (Amst). 2024 Jan;133:103594. doi: 10.1016/j.dnarep.2023.103594. Epub 2023 Nov 13.
2
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors.ATM 抑制剂 M3541 联合姑息性放疗治疗实体瘤患者的 I 期临床试验。
Invest New Drugs. 2022 Jun;40(3):596-605. doi: 10.1007/s10637-022-01216-8. Epub 2022 Feb 12.
3
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications.
胰腺腺癌中的 ATM 功能障碍及其相关治疗意义。
Mol Cancer Ther. 2019 Nov;18(11):1899-1908. doi: 10.1158/1535-7163.MCT-19-0208.